The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)

Peplin

Overview

Verruca vulgaris, otherwise known as the common wart, is caused by the human papillomavirus (HPV). Common warts are generally located on the hands and feet, but can also occur elsewhere (e.g., any areas of frequent contact). Common warts have a characteristic cauliflower-like surface, are typically slightly raised above the surrounding skin and are generally diagnosed by visual inspection.The treatment of warts poses a therapeutic challenge for physicians. No single therapy has been proven effective at achieving complete remission in every patient.This study will aim to evaluate an up-to a three-day course of therapy with 0.05% PEP005 Topical Gel.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Conditions

Warts

Interventions

PEP005DRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male and female patients at least 18 years of age. * A clinically diagnosed, single common cutaneous viral wart (verruca vulgaris) on the dorsal hand. * Written informed consent has been obtained. * Agreement from the patient to allow photographs of the common wart(s) treatment area to be taken and used as part of the study package.

Locations (1)

South East Dermatology, 1202 Creek Rd

Carina Heights, Brisbane, Queensland, Australia

Outcomes

Primary Outcomes

Safety

Secondary Outcomes

Resolution of Common Wart(s)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.